PHR1346
Methylsulfonylmethane
Pharmaceutical Secondary Standard; Certified Reference Material
Szinonimák:
Dimethyl sulfone, Methyl sulfone
Bejelentkezésa Szervezeti és Szerződéses árazás megtekintéséhez
Összes fotó(1)
About This Item
Lineáris képlet:
(CH3)2SO2
CAS-szám:
Molekulatömeg:
94.13
Beilstein:
1737717
EC-szám:
MDL-szám:
UNSPSC kód:
41116107
PubChem Substance ID:
NACRES:
NA.24
Javasolt termékek
grade
certified reference material
pharmaceutical secondary standard
Minőségi szint
Ügynökség
traceable to USP 1437600
API-család
methylsulfonylmethane
Analitikai műbizonylat
current certificate can be downloaded
technika/technikák
HPLC: suitable
gas chromatography (GC): suitable
bp
238 °C (lit.)
mp
107-109 °C (lit.)
alkalmazás(ok)
pharmaceutical (small molecule)
format
neat
tárolási hőmérséklet
2-30°C
SMILES string
CS(C)(=O)=O
InChI
1S/C2H6O2S/c1-5(2,3)4/h1-2H3
Nemzetközi kémiai azonosító kulcs
HHVIBTZHLRERCL-UHFFFAOYSA-N
Looking for similar products? Látogasson el ide Útmutató a termékösszehasonlításhoz
Általános leírás
Methylsulfonylmethane is the oxidized form of dimethyl sulfoxide, generally occurring in green plants, fruits and vegetables. Methylsulfonylmethane can find applications as a solvent to dissolve a wide range of solutes and is also generally used for high temperature reactions. It exhibits pharmacological properties and is reported to reduce peripheral pain, inflammation and arthritis condition.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Alkalmazás
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Analízis megjegyzés
These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.
Egyéb megjegyzések
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
Lábjegyzet
To see an example of a Certificate of Analysis for this material enter LRAC3469 in the slot below. This is an example certificate only and may not be the lot that you receive.
kapcsolódó termék
Product No.
Leírás
Árazás
Tárolási osztály kódja
11 - Combustible Solids
WGK
WGK 1
Lobbanási pont (F)
Not applicable
Lobbanási pont (C)
Not applicable
Válasszon a legfrissebb verziók közül:
Már rendelkezik ezzel a termékkel?
Az Ön által nemrégiben megvásárolt termékekre vonatkozó dokumentumokat a Dokumentumtárban találja.
Az ügyfelek ezeket is megtekintették
Meta-analysis of the related nutritional supplements dimethyl sulfoxide and methylsulfonylmethane in the treatment of osteoarthritis of the knee
Brien S, et al.
Evidence-Based Complementary and Alternative Medicine (2011)
Methylsulfonylmethane (MSM). Monograph.
Alternative medicine review : a journal of clinical therapeutic, 8(4), 438-441 (2003-12-05)
Jacob F Smith et al.
Frontiers in physiology, 11, 80-80 (2020-03-07)
Osteoarthritis (OA) is a degenerative joint disease characterized by inflammatory degradation of articular cartilage and subchondral bone. Wogonin, a compound extracted from the plant Scutellaria baicalensis (colloquially known as skullcap), has previously been shown to have direct anti-inflammatory and antioxidative
S Brien et al.
Osteoarthritis and cartilage, 16(11), 1277-1288 (2008-04-18)
Conventional treatment of osteoarthritis (OA) with non-steroidal anti-inflammatory drugs is associated with serious gastrointestinal side effects and in view of the recent withdrawal of some cyclo-oxygenase-2 inhibitors, identifying safer alternative treatment options is needed. The objective of this systematic review
Youn Hee Joung et al.
International journal of oncology, 44(3), 883-895 (2014-01-10)
Human urinary bladder cancer is the fifth most common cancer, with a worldwide estimate of about two million patients. Recurrence after complete transurethral prostatic resection is the most important problem in therapy. Combination therapy is a new approach in the
Tudóscsoportunk valamennyi kutatási területen rendelkezik tapasztalattal, beleértve az élettudományt, az anyagtudományt, a kémiai szintézist, a kromatográfiát, az analitikát és még sok más területet.
Lépjen kapcsolatba a szaktanácsadással